Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Depressed Patients Hospitalized in Southeast-Facing Rooms Are Discharged Earlier than Patients in Northwest-Facing Rooms

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Season of birth in Danish children with language disorder born in the 1958-1976 period

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Duffy-null genotype and risk of infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Letter to the editor regarding "Have you ever experienced a headache of any kind?"

    Research output: Contribution to journalLetterResearchpeer-review

  4. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The impact of low-risk genetic variants in self-limited epilepsy with centrotemporal spikes aka Rolandic epilepsy

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations
OBJECTIVE: The aim of the present retrospective pilot study was to examine the clinical impact of the cytochrome P450 (CYP) enzyme CYP2D6 poor metabolizer (PM) genotype in patients taking antipsychotic medication. The impaired metabolic capacity of the PM genotype results in higher steady-state plasma concentrations at a given dose, thus increasing the risk of toxic effects from medication. METHODS: We identified 18 PM patients with a schizophrenia spectrum diagnosis from a clinical database covering all patients who have been analyzed in an ongoing standardized CYP2D6 screening program. Each PM patient was carefully matched on age, gender and diagnosis with an intermediate metabolizer (IM) and an extensive metabolizer (EM) from the same database to generate 18 triplets. Clinical data, primarily on side effects of treatment, were obtained from medical records by an experienced research and consultant psychiatrist, who was blinded to the results of the genotyping. RESULTS: We found that extrapyramidal syndrome or tardive dyskinesia (EPS/TD) was significantly more frequent among PM patients than among the matched IM and EM control subjects. This finding was further supported by the significantly higher prevalence of noncompliance among the same PM patients. Importantly, this association was not due to differences in the use of CYP2D6-dependent or EPS/TD-causing medication across the 3 matched patient groups. CONCLUSIONS: This leads us to conclude that genetically encoded differences in the rate of drug metabolism through CYP2D6 can predict antipsychotic side effects and prompts the question of whether genotyping early in the course of illness to facilitate adjustment of pharmacotherapy will improve treatment outcomes and reduce side effects.
Original languageEnglish
JournalNeuropsychobiology
Volume59
Issue number4
Pages (from-to)222-6
Number of pages4
ISSN0302-282X
DOIs
Publication statusPublished - 2009

Bibliographical note

Keywords: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Case-Control Studies; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Medication Adherence; Middle Aged; Pilot Projects; Retrospective Studies; Schizophrenia; Sequence Analysis, DNA

ID: 171410